• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-600
Device Problem Imprecision (1307)
Patient Problems Hyperglycemia (1905); Hypoglycemia (1912)
Event Date 01/05/2023
Event Type  malfunction  
Manufacturer Narrative
The manufacturer is currently performing an investigation and will provide the results with the supplemental report.
 
Event Description
On (b)(6) 2023, senseonics was made aware of an adverse event where user experienced hypoglycemia due to inaccuracies in sensor readings.
 
Manufacturer Narrative
H6.Clinical code corrected to 1905.
 
Event Description
On 06 january 2023, senseonics was made aware of an adverse event where user experienced false hyperglycemia alerts due to inaccuracies in sensor readings.
 
Manufacturer Narrative
Based on the investigation analysis, it was confirmed that the system displayed a temporary mismatch between the blood glucose and sugar glucose measurements at the time of the incident.The sensor data was reviewed from the prior two weeks and there was no indication of any sensor performance issue, as the sensor readings closely matched the calibration entries.The exact cause of the temporary mismatch at the time of the event could not be determined and there were no signs of sensor malfunction.Temporary mismatch could occur if past calibrations entered were not accurate, or the calibration on the day of the event was reported in error, or it could be due to occasional differences that the system produces.The overall sensor performance was evaluated, and it was performing within expectations.The user ate something to increase her glucose levels.The user is currently using the system with up-to-date information.The current system performance is within expectations.H3: device evaluated by manufacturer? yes.H6: investigation findings updated to 114.H6: investigation conclusions updated to 4315.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20875-7005
MDR Report Key16280543
MDR Text Key308606163
Report Number3009862700-2023-00020
Device Sequence Number1
Product Code QHJ
UDI-Device Identifier00817491022912
UDI-Public817491022912
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 01/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/25/2023
Device Model Number102208-600
Device Catalogue NumberFG-5900-01-001
Device Lot Number129860
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/06/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/25/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age54 YR
Patient SexFemale
Patient EthnicityNon Hispanic
-
-